WITHDRAWN: A multicenter, randomized, controlled trial of rebamipide plus lansoprazole for the treatment of post-endoscopic submucosal dissection ulcers
Abstract
// Bin Yan 1, * , Zhongsheng Lu 1, * , Zhizheng Ge 2 , Side Liu 3 , Xuegang Guo 4 , Dean Tian 5 , Yuxiu Yang 6 , Xiaobo Li 2 , Wei Gong 3 , Zhiguo Liu 4 , Mei Liu 5 , Bingxi Zhou 6 , Kabing Zhao 1 , Jing Yang 1 and Yunsheng Yang 1 1 Department of Gastroenterology and Hepatology, Chinese PLA General Hospital, Beijing, China 2 Department of Gastroenterology and Hepatology, Renji Hospital, Shanghai, China 3 Department of Gastroenterology and Hepatology, Nanfang Hospital, Guangzhou, Guangdong Province, China 4 Department of Gastroenterology and Hepatology, Xijing Hospital, Xian, Shanxi province, China 5 Department of Gastroenterology and Hepatology, Tongji Hospital, Wuhan, Hubei province, China 6 Department of Gastroenterology and Hepatology, Henan Provincial People’s Hospital, Zhengzhou, Henan Province, China * These authors contributed equally to this work Correspondence to: Yunsheng Yang, email: [email protected] Keywords: randomized clinical trial; endoscopic submucosal dissection; ulcer; lansoprazole; rebamipide Received: September 29, 2017 Accepted: November 15, 2017 Published: January 02, 2018 ABSTRACT Objective: To evaluate the healing efficacy of rebamipide and lansoprazole combination therapy with lansoprazole alone for endoscopic submucosal dissection (ESD)–induced ulcers and clarify the ulcer healing-associated factors. Materials and Methods: Three hundred patients were randomized into control and experimental groups after undergoing ESD. The patients received…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 56 participants or records.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.